	Inhaled Targeted Nano-Drug Delivery Systems for COPD: Precision Solutions to Clinical Barriers. Int J Nanomedicine Liu Y, Wang Q, He M, Xu X, Wang X, Chen Q. PMID: 42835819 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease with Osteoporosis: A Systematic Review and Meta-Analysis. Int J Chron Obstruct Pulmon Dis Li X, Wang H, Zhang H, Hu X, Gao F, Wang B. PMID: 42835775 [PubMed - indexed for MEDLINE]
	COPD trial wins spur broad respiratory hopes. Nat Rev Drug Discov Mullard A. PMID: 42834102 [PubMed - as supplied by publisher]
	Early versus late escalation to extrafine BDP/FF/GB single-inhaler triple therapy in COPD: a real-world subgroup analysis by disease duration since diagnosis. Respir Med Rogliani P, Brusselle G, Stolz D, Piraino A, Franzini L, Di Palma L, Nudo E, Bakakos P. PMID: 42833477 [PubMed - as supplied by publisher]
	Sex Differences in Delivery of Guideline-Recommended COPD Care: A National U.S. Cohort. Respir Med Hamann KM, Wendt CH, Baldomero AK. PMID: 42833476 [PubMed - as supplied by publisher]
	Unmet Needs and New Opportunities in Chronic Obstructive Pulmonary Disease in Italy: A Narrative Review with Insights from the GULP Study. Int J Chron Obstruct Pulmon Dis Radovanovic D, Braido F, Contoli M, Corsico AG, Di Marco F, Micheletto C, Pelaia G, Rogliani P, Scichilone N, Solidoro P, Santus P. PMID: 42831088 [PubMed - indexed for MEDLINE]
	Beyond Blood Eosinophils: Target-Tier Heterogeneity and Patient Enrichment in COPD Type 2 Inflammation. J Inflamm Res Zhang J, Zhang P, Zhang Y, Xie Y. PMID: 42831046 [PubMed]
	Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies. J Inflamm Res Dou M, Zhang X, Zhang M. PMID: 42830888 [PubMed]
	Associations of Maximal Inspiratory Pressure With Lung Hyperinflation, Functional Capacity, and Muscle Strength in Patients With Chronic Obstructive Pulmonary Disease. Physiother Res Int Kraisalee J, Chaiwong W, Lungta T, Vimolsutjarit N, Prasannarong M, Deesomchok A, Dacha S. PMID: 42830417 [PubMed - indexed for MEDLINE]
	ADAMTS5 May Serve as a Useful Biomarker for Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis Yang Q, Nie Y, Wang J, Liu X, Wen Y, Hou J, Hua S, Li L, Sun S. PMID: 42829719 [PubMed - indexed for MEDLINE]
	Trends of Platelet Indices in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Longitudinal Follow-Up Study. Cureus M S, Igno SS, B N, Rajarethinam B. PMID: 42828396 [PubMed]
	The Association Between Chronic Obstructive Pulmonary Disease and the Risks of Falls and Osteoporosis: A Cohort Study in the UK Biobank. Int J Chron Obstruct Pulmon Dis Liu P, Nie L, Tan Y, Peng H, Zheng Y, Guo H, Yang Z, Wu T, Huang J, Wang M. PMID: 42827947 [PubMed - indexed for MEDLINE]
	The burden and long-term outcomes of diagnosed and underdiagnosed COPD across diverse communities from high-income, middle-income, and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study. Lancet Glob Health Duong M, Kang E, Rangarajan S, Ramacham Parambath S, Rosengren A, Nair S, Lanas F, Ma X, Liu Z, Ah Tse L, Mony PK, Mir H, Abat MEM, Lakshmi PVM, Alhabib KF, Assembekov B, Avezum A, Bahonar A, Barbarash O, Chifamba J, Luz Diaz M, Erkin M, Felix C, Iqbal R, Khatib R, Lopez-Jaramillo P, Mat-Nasir N, Oguz A, Swart EC, Yeates K, Yusuf R, Yusufali A, Zato, Teo KK, Yusuf S, PURE investigators. PMID: 42826728 [PubMed - as supplied by publisher]
	Trends in mortality involving chronic obstructive pulmonary disease and obesity in the United States, 1999-2023: A population-based observational study. Medicine (Baltimore) Khan AA, Hussain SA, Ahmad ZB, Ali R, Aminpoor H, Hanif L, Khan MS, Mahfooz A, Uddin MS, Qureshi S. PMID: 42826321 [PubMed - indexed for MEDLINE]
	Systemic inflammation response index: A good predictor of 30-day all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. Medicine (Baltimore) Bai Y. PMID: 42826271 [PubMed - indexed for MEDLINE]
	Cytokine Expression and Promoter Methylation Signatures Underlying Immune Dysregulation in Mild and Severe COPD. Iran J Allergy Asthma Immunol Faghih Ojaroodi A, Gholamzadeh N, Pouya K, Abbaspour-Aghdam S, Mikaeili H, Sadeghi A, Ahmadi M, Nadiri M. PMID: 42825916 [PubMed - indexed for MEDLINE]
	Clinical and Inflammatory Benefits of Nebulized Furosemide with Salbutamol-Ipratropium in COPD Exacerbations: A Randomized Controlled Trial. Iran J Allergy Asthma Immunol Behi M, Gholamine B, Masjedi MR, Eslaminejad A, Idani E, Sadeghi M, Qanavati A, Marashian SM, Mortaz E, Abedini A, Pourabdollah M, Pakshad B, Mahmoodian S. PMID: 42825900 [PubMed - indexed for MEDLINE]
	Social Isolation Experiences in Patients With Chronic Obstructive Pulmonary Disease: A Qualitative Study. J Clin Nurs Xiao C, Feng Y, Xiao Y, Li S, Song X. PMID: 42823634 [PubMed - as supplied by publisher]
	Clinical Characteristics and Factors Associated with One-Year Smoking Cessation Among Smokers with COPD: A Subgroup Analysis of a Multicentre Randomised Trial. Int J Chron Obstruct Pulmon Dis Mar, Karado, Telatar TG, Kaya , Atl, Köse Kabil N, Yumrukuz , Yüksel A, Yalç, Gültekin Ö, Erçelik M, Akgün M. PMID: 42820089 [PubMed - indexed for MEDLINE]
	Nonparametric Prioritization of Breath VOC Signatures for Differential Diagnosis of Asthma, Bronchiectasis, and COPD. J Breath Res Kwon HJ, Rivera EC, Bustamante J, Andersen J. PMID: 42822498 [PubMed - as supplied by publisher]

Articles 1 - 20 / 46968

Page 1 of 2349



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy